 TORRANCE, Calif.--BUSINESS WIRE--Forte Biosciences, Inc. NASDAQ: FBRX, a clinical-stage biopharmaceutical company, today announced the issuance of equity inducement awards as required by the Nasdaq Stock Market Rules. In accordance with NASDAQ Listing Rule 5635c4, the Compensation Committee of Fortes Board of Directors approved the grant of equity awards to purchase a total of 35,000 shares of common stock to new non-executive employees as a material inducement to 